$6.46 Billion is the total value of Orbimed Advisors's 124 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 45.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $467,348,000 | +82.5% | 3,970,673 | -2.9% | 7.24% | +52.8% |
| TCDA | TRICIDA INC | $420,544,000 | +63.8% | 10,889,280 | 0.0% | 6.51% | +37.1% | |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $272,098,000 | +121.9% | 10,425,225 | 0.0% | 4.21% | +85.8% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $264,574,000 | +32.7% | 1,957,200 | -4.4% | 4.10% | +11.1% |
| ALEC | New | ALECTOR INC | $246,773,000 | – | 13,182,329 | +100.0% | 3.82% | – |
| BSX | BOSTON SCIENTIFIC CORP | $222,236,000 | +8.6% | 5,790,400 | 0.0% | 3.44% | -9.1% | |
| MRK | Buy | MERCK & CO INC | $213,755,000 | +12.1% | 2,570,100 | +3.0% | 3.31% | -6.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $175,727,000 | -6.4% | 955,300 | -15.7% | 2.72% | -21.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $161,505,000 | +357.6% | 1,833,200 | +270.9% | 2.50% | +282.8% |
| MYL | Buy | MYLAN N V | $137,783,000 | +26.1% | 4,861,800 | +22.0% | 2.13% | +5.6% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $136,801,000 | +91.8% | 715,000 | +53.6% | 2.12% | +60.6% |
| WMGI | Sell | WRIGHT MED GROUP N V | $131,706,000 | -1.4% | 4,187,799 | -14.6% | 2.04% | -17.4% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $122,435,000 | +25.1% | 447,300 | +2.2% | 1.90% | +4.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $119,993,000 | +46.9% | 210,300 | +23.3% | 1.86% | +23.0% |
| GH | GUARDANT HEALTH INC | $117,693,000 | +104.0% | 1,534,464 | 0.0% | 1.82% | +70.8% | |
| THOR | SYNTHORX INC | $108,294,000 | +17.2% | 5,316,355 | 0.0% | 1.68% | -1.9% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $98,737,000 | +15.8% | 828,400 | +6.1% | 1.53% | -3.0% |
| ANTM | Buy | ANTHEM INC | $93,326,000 | +16.4% | 325,200 | +6.5% | 1.44% | -2.6% |
| BHC | Buy | BAUSCH HEALTH COS INC | $92,395,000 | +38.9% | 3,740,700 | +3.9% | 1.43% | +16.3% |
| PRNB | PRINCIPIA BIOPHARMA INC | $88,594,000 | +24.1% | 2,605,713 | 0.0% | 1.37% | +3.9% | |
| REGN | Sell | REGENERON PHARMACEUTICALS | $88,201,000 | +6.3% | 214,800 | -3.3% | 1.36% | -11.0% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $83,978,000 | +63.8% | 3,618,171 | +48.2% | 1.30% | +37.1% |
| INSP | Sell | INSPIRE MED SYS INC | $83,523,000 | +8.1% | 1,471,000 | -19.6% | 1.29% | -9.5% |
| IMMU | Sell | IMMUNOMEDICS INC | $82,034,000 | +15.7% | 4,270,403 | -14.0% | 1.27% | -3.1% |
| EHTH | Buy | EHEALTH INC | $73,637,000 | +74.2% | 1,181,214 | +7.4% | 1.14% | +46.0% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $72,925,000 | +37.9% | 1,880,000 | -27.7% | 1.13% | +15.4% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $70,821,000 | +75.4% | 1,815,000 | -4.1% | 1.10% | +46.9% |
| ILMN | Sell | ILLUMINA INC | $70,620,000 | -4.2% | 227,300 | -7.6% | 1.09% | -19.9% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $70,298,000 | +42.2% | 2,832,300 | +2.9% | 1.09% | +19.0% |
| EXEL | EXELIXIS INC | $66,685,000 | +21.0% | 2,801,900 | 0.0% | 1.03% | +1.3% | |
| A | Buy | AGILENT TECHNOLOGIES INC | $64,200,000 | +26.4% | 798,700 | +6.1% | 0.99% | +5.9% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $63,959,000 | – | 4,079,000 | +100.0% | 0.99% | – |
| LOGC | LOGICBIO THERAPEUTICS INC | $63,892,000 | -5.0% | 6,466,783 | 0.0% | 0.99% | -20.5% | |
| PTCT | PTC THERAPEUTICS INC | $57,202,000 | +9.7% | 1,519,700 | 0.0% | 0.89% | -8.1% | |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $57,013,000 | +116.8% | 1,195,000 | +136.2% | 0.88% | +81.7% |
| HUM | Buy | HUMANA INC | $55,940,000 | -5.4% | 210,300 | +1.8% | 0.87% | -20.8% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $52,765,000 | +7.5% | 5,548,326 | 0.0% | 0.82% | -10.0% | |
| AVDR | New | AVEDRO INC | $52,026,000 | – | 4,240,128 | +100.0% | 0.80% | – |
| ENDP | New | ENDO INTL PLC | $49,509,000 | – | 6,165,464 | +100.0% | 0.77% | – |
| ABT | Buy | ABBOTT LABS | $49,195,000 | +51.7% | 615,400 | +37.2% | 0.76% | +27.0% |
| MYOK | Buy | MYOKARDIA INC | $47,134,000 | +187.9% | 906,600 | +170.5% | 0.73% | +140.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $45,105,000 | -27.5% | 361,300 | -44.2% | 0.70% | -39.3% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $43,569,000 | -24.1% | 1,914,282 | 0.0% | 0.67% | -36.5% | |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $42,390,000 | +835.8% | 2,460,251 | +423.5% | 0.66% | +681.0% |
| ZLAB | Sell | ZAI LAB LTDadr | $41,353,000 | +1.6% | 1,401,318 | -20.1% | 0.64% | -15.0% |
| CI | Sell | CIGNA CORP NEW | $40,623,000 | -55.7% | 252,600 | -47.7% | 0.63% | -62.9% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $40,088,000 | +11.4% | 631,300 | -33.4% | 0.62% | -6.8% |
| ARVN | ARVINAS INC | $39,539,000 | +14.9% | 2,678,810 | 0.0% | 0.61% | -3.9% | |
| VRAY | VIEWRAY INC | $38,051,000 | +21.7% | 5,149,019 | 0.0% | 0.59% | +1.9% | |
| BGNE | BEIGENE LTDsponsored adr | $37,290,000 | -5.9% | 282,500 | 0.0% | 0.58% | -21.3% | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $34,365,000 | +696.8% | 1,762,300 | +438.9% | 0.53% | +565.0% |
| OBSV | OBSEVA SA | $33,325,000 | +1.0% | 2,605,531 | 0.0% | 0.52% | -15.4% | |
| TORC | RESTORBIO INC | $32,943,000 | -20.9% | 4,830,387 | 0.0% | 0.51% | -33.8% | |
| PRTA | New | PROTHENA CORP PLC | $29,540,000 | – | 2,435,278 | +100.0% | 0.46% | – |
| GNFT | New | GENFIT S Aads | $29,528,000 | – | 1,230,314 | +100.0% | 0.46% | – |
| GILD | GILEAD SCIENCES INC | $28,851,000 | +3.9% | 443,800 | 0.0% | 0.45% | -12.9% | |
| KALA | KALA PHARMACEUTICALS INC | $28,514,000 | +69.1% | 3,447,840 | 0.0% | 0.44% | +41.3% | |
| XTNT | XTANT MED HLDGS INC | $28,081,000 | +89.4% | 9,207,012 | 0.0% | 0.44% | +58.8% | |
| CELG | Sell | CELGENE CORP | $27,830,000 | -86.7% | 295,000 | -90.9% | 0.43% | -88.8% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $27,491,000 | +21.2% | 1,982,031 | +37.9% | 0.43% | +1.4% |
| CDNA | New | CAREDX INC | $26,086,000 | – | 827,600 | +100.0% | 0.40% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $26,126,000 | -28.1% | 1,069,000 | -23.7% | 0.40% | -39.9% |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $25,183,000 | +107.5% | 3,670,955 | +11.3% | 0.39% | +74.1% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $24,899,000 | – | 1,874,955 | +100.0% | 0.38% | – |
| CRVS | CORVUS PHARMACEUTICALS INC | $23,990,000 | +9.5% | 5,967,584 | 0.0% | 0.37% | -8.4% | |
| HARP | New | HARPOON THERAPEUTICS INC | $23,167,000 | – | 2,446,409 | +100.0% | 0.36% | – |
| AMGN | AMGEN INC | $23,197,000 | -2.4% | 122,100 | 0.0% | 0.36% | -18.4% | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $22,266,000 | – | 233,100 | +100.0% | 0.34% | – |
| NTRA | Buy | NATERA INC | $22,220,000 | +132.7% | 1,077,586 | +57.5% | 0.34% | +94.4% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCput | $22,208,000 | – | 250,000 | +100.0% | 0.34% | – |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $21,580,000 | -13.5% | 787,300 | -15.2% | 0.33% | -27.7% |
| BIIB | Sell | BIOGEN INC | $20,731,000 | -91.8% | 87,700 | -89.5% | 0.32% | -93.1% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $20,474,000 | – | 3,149,810 | +100.0% | 0.32% | – |
| TAK | New | TAKEDA PHARMACEUTICAL CO LTDcall | $20,370,000 | – | 1,000,000 | +100.0% | 0.32% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $19,614,000 | -13.0% | 996,123 | 0.0% | 0.30% | -27.1% | |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $19,482,000 | +4.5% | 5,195,330 | 0.0% | 0.30% | -12.5% | |
| SIBN | SI BONE INC | $18,564,000 | -9.8% | 985,368 | 0.0% | 0.29% | -24.7% | |
| SVA | SINOVAC BIOTECH LTD | $18,372,000 | -6.8% | 2,839,500 | 0.0% | 0.28% | -22.0% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $17,432,000 | +7.5% | 2,165,524 | 0.0% | 0.27% | -10.0% | |
| NVO | NOVO-NORDISK A Sadr | $17,262,000 | +13.5% | 330,000 | 0.0% | 0.27% | -5.0% | |
| DXCM | DEXCOM INC | $16,519,000 | -0.6% | 138,700 | 0.0% | 0.26% | -16.6% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $15,996,000 | +32.6% | 1,479,733 | 0.0% | 0.25% | +11.2% | |
| SYBX | SYNLOGIC INC | $15,408,000 | +8.3% | 2,029,996 | 0.0% | 0.24% | -9.1% | |
| TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $15,278,000 | – | 750,000 | +100.0% | 0.24% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $14,124,000 | – | 50,000 | +100.0% | 0.22% | – |
| CNST | CONSTELLATION PHARMCETICLS I | $11,326,000 | +237.9% | 835,842 | 0.0% | 0.18% | +182.3% | |
| NABRIVA THERAPEUTICS PLC | $11,333,000 | +67.1% | 4,644,600 | 0.0% | 0.18% | +40.0% | ||
| SYK | Sell | STRYKER CORP | $10,666,000 | -47.7% | 54,000 | -58.5% | 0.16% | -56.2% |
| SCPH | SCPHARMACEUTICALS INC | $10,230,000 | -20.2% | 3,409,865 | 0.0% | 0.16% | -33.3% | |
| NVUS | NOVUS THERAPEUTICS INC | $10,199,000 | +151.3% | 2,537,110 | 0.0% | 0.16% | +110.7% | |
| MRSN | New | MERSANA THERAPEUTICS INC | $9,947,000 | – | 1,891,119 | +100.0% | 0.15% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $9,707,000 | +780.9% | 467,600 | +477.3% | 0.15% | +650.0% |
| VRNA | VERONA PHARMA PLCsponsored ads | $8,128,000 | -32.6% | 1,250,396 | 0.0% | 0.13% | -43.5% | |
| WMGI | New | WRIGHT MED GROUP N Vcall | $7,863,000 | – | 250,000 | +100.0% | 0.12% | – |
| AMRN | New | AMARIN CORP PLCcall | $7,266,000 | – | 350,000 | +100.0% | 0.11% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $7,049,000 | +127.8% | 518,309 | +60.5% | 0.11% | +91.2% |
| WVE | New | WAVE LIFE SCIENCES LTDput | $6,993,000 | – | 180,000 | +100.0% | 0.11% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,823,000 | +62.5% | 2,879,064 | +82.3% | 0.11% | +35.9% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,795,000 | +4.3% | 76,500 | 0.0% | 0.10% | -12.5% | |
| SPRO | New | SPERO THERAPEUTICS INC | $6,501,000 | – | 507,471 | +100.0% | 0.10% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $6,514,000 | – | 1,243,200 | +100.0% | 0.10% | – |
| XENE | XENON PHARMACEUTICALS INC | $6,450,000 | +61.0% | 634,812 | 0.0% | 0.10% | +35.1% | |
| NTLA | INTELLIA THERAPEUTICS INC | $6,449,000 | +25.1% | 377,600 | 0.0% | 0.10% | +5.3% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $5,808,000 | -25.2% | 1,350,655 | 0.0% | 0.09% | -37.5% | |
| XFOR | New | X4 PHARMACEUTICALS INC | $5,423,000 | – | 311,493 | +100.0% | 0.08% | – |
| ATNX | ATHENEX INC | $5,268,000 | -3.5% | 430,000 | 0.0% | 0.08% | -18.8% | |
| NVTA | Sell | INVITAE CORP | $5,200,000 | -43.0% | 222,017 | -73.1% | 0.08% | -52.7% |
| MNLO | New | MENLO THERAPEUTICS INC | $4,976,000 | – | 633,920 | +100.0% | 0.08% | – |
| CTIC | CTI BIOPHARMA CORP | $4,851,000 | +32.3% | 5,000,000 | 0.0% | 0.08% | +10.3% | |
| ARPO | AERPIO PHARMACEUTICALS INC | $4,680,000 | -47.0% | 5,193,946 | 0.0% | 0.07% | -55.8% | |
| AVRO | Sell | AVROBIO INC | $4,379,000 | +5.2% | 198,583 | -20.5% | 0.07% | -11.7% |
| RLM | REALM THERAPEUTICS PLCsponsored ads | $3,933,000 | +108.1% | 1,021,484 | 0.0% | 0.06% | +74.3% | |
| NVTRQ | NUVECTRA CORP | $3,854,000 | -32.6% | 350,000 | 0.0% | 0.06% | -43.4% | |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $2,755,000 | -91.2% | 58,000 | -93.3% | 0.04% | -92.6% |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $2,590,000 | – | 90,500 | +100.0% | 0.04% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $1,948,000 | – | 59,210 | +100.0% | 0.03% | – |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $1,664,000 | +16.4% | 398,101 | -20.1% | 0.03% | 0.0% |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $1,463,000 | – | 75,000 | +100.0% | 0.02% | – |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $1,381,000 | -17.6% | 2,000,000 | 0.0% | 0.02% | -32.3% | ||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1,113,000 | +18.0% | 212,000 | 0.0% | 0.02% | 0.0% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $542,000 | -1.6% | 317,104 | -24.0% | 0.01% | -20.0% |
| BLRX | BIOLINERX LTDsponsored ads | $447,000 | -1.5% | 1,038,600 | 0.0% | 0.01% | -12.5% | |
| REPH | Sell | RECRO PHARMA INC | $255,000 | -66.5% | 43,499 | -59.5% | 0.00% | -71.4% |
| MDGS | MEDIGUS LTDsponsored ads | $44,000 | +12.8% | 15,000 | 0.0% | 0.00% | 0.0% | |
| WMGIZ | Exit | WRIGHT MED GROUP N Vright 03/01/2019 | $0 | – | -8,746,583 | -100.0% | -0.00% | – |
| ALIM | Exit | ALIMERA SCIENCES INC | $0 | – | -250,000 | -100.0% | -0.00% | – |
| RDHL | Exit | REDHILL BIOPHARMA LTDsponsored ads | $0 | – | -54,600 | -100.0% | -0.01% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.02% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -54,600 | -100.0% | -0.02% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -326,650 | -100.0% | -0.02% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -100,000 | -100.0% | -0.03% | – |
| ECOR | Exit | ELECTROCORE INC | $0 | – | -397,826 | -100.0% | -0.05% | – |
| RMED | Exit | RA MED SYS INC | $0 | – | -350,000 | -100.0% | -0.05% | – |
| YI | Exit | 111 INCads | $0 | – | -500,000 | -100.0% | -0.06% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -36,300 | -100.0% | -0.06% | – |
| ASNS | Exit | ARSANIS INC | $0 | – | -1,868,966 | -100.0% | -0.08% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -47,800 | -100.0% | -0.09% | – |
| CELG | Exit | CELGENE CORPcall | $0 | – | -100,000 | -100.0% | -0.12% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -66,000 | -100.0% | -0.12% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -1,031,596 | -100.0% | -0.14% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORPcall | $0 | – | -250,000 | -100.0% | -0.16% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -175,000 | -100.0% | -0.17% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -75,900 | -100.0% | -0.18% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -562,785 | -100.0% | -0.18% | – |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -16,952,000 | -100.0% | -0.22% | – | |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -1,440,000 | -100.0% | -0.25% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -2,265,500 | -100.0% | -0.37% | – |
| SHPG | Exit | SHIRE PLCcall | $0 | – | -150,000 | -100.0% | -0.48% | – |
| PFE | Exit | PFIZER INC | $0 | – | -602,200 | -100.0% | -0.49% | – |
| DVA | Exit | DAVITA INC | $0 | – | -534,000 | -100.0% | -0.51% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -2,878,000 | -100.0% | -0.55% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -305,000 | -100.0% | -0.66% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -387,200 | -100.0% | -0.71% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -186,500 | -100.0% | -0.86% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -417,400 | -100.0% | -0.89% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -793,800 | -100.0% | -0.96% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -957,000 | -100.0% | -2.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.